AquaBounty Technologies, Inc. (AQB) is a Materials stock trading at $1.31 (as of 2026-08-21), with a market capitalization of $6.77M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
AquaBounty Technologies, Inc. is a biotechnology company focused on aquaculture in the United States and Canada, including research in genetic and genomic methods and fish health and nutrition. It produces and sells AquAdvantage Salmon and also sells conventional Atlantic salmon, salmon eggs, fry, and related byproducts for human consumption.
AquaBounty Technologies develops biotech solutions for commercial aquaculture, selling AquAdvantage Salmon (a bioengineered Atlantic salmon for human consumption) and also selling conventional Atlantic salmon, salmon eggs, fry, and byproducts.
The profit model is driven by product sales from its commercial aquaculture offering, mainly AquAdvantage Salmon, plus conventional Atlantic salmon and related products (eggs, fry, byproducts) supported by its genetic, genomic, and fish health and nutrition research.
Business quality (Weak): The provided facts clearly describe what AquaBounty sells and how it operates, but there is no official segment breakdown or operating KPI data included here, limiting how precisely we can evaluate ongoing performance drivers.
| Price | $1.31 |
| Market Cap | $6.77M |
| Price / Book | 2.41 |
| Price / Sales | 4.71 |
| Revenue (TTM) | $2.47M |
| Net Margin | -1114.5% |
| Sector P/E (Materials) | 25.9 |
| Industry P/E (Other) | 26.0 |
| Top Institutional Holder | INDEPENDENT FINANCIAL GROUP, LLC ($109763.00) |
| Institutional Holders Tracked | 10 |
| Sector | Materials |
| Industry | Other |
| CEO | David A. Frank |
| Employees | 4 |
| Country | US |
| IPO Date | 2017-01-11 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.